RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.8600
-0.0144 (-1.65%)
Apr 25, 2025, 12:44 PM EDT - Market open
RAPT Therapeutics Employees
RAPT Therapeutics had 68 employees as of December 31, 2024. The number of employees decreased by 63 or -48.09% compared to the previous year.
Employees
68
Change (1Y)
-63
Growth (1Y)
-48.09%
Revenue / Employee
n/a
Profits / Employee
-$1,909,779
Market Cap
113.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
RAPT News
- 10 days ago - RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development - GlobeNewsWire
- 6 weeks ago - RAPT Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors - GlobeNewsWire
- 4 months ago - RAPT Therapeutics Announces $150 Million Private Placement - GlobeNewsWire
- 5 months ago - Rapt Therapeutics Stock Plummets, Terminates Asthma Trial Due To Patient's Liver Injury - Benzinga
- 9 months ago - RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus - Seeking Alpha